Instrument Business Outlook

View more issues:

Articles in July 15, 2002 issue of Instrument Business Outlook

• Opportunities in the Russian instrument market: part I
• Veeco and FEI to merge
• IDEX buys Rheodyne
• Waters and Micromass to integrate
• Harvard Bioscience acquires spectrophotometer company
• Qiagen and Bruker Daltonics lower 2002 forecasts
• Dionex names new president and CEO
• First quarter filtration sales stay healthy
• Instrument industry R&D commitment continues to be strong
• Genomics: scientists at Decode Genetics in Reykjavik, Iceland report that the latest version of the human genome map, released in August 2001 by the public consortium, contains 104 serious errors
• Semiconductors: the global book-to-bill figures for the first quarter of 2002, released by Semiconductor Equipment and Materials International , showed that worldwide billings totaled $4.05 billion, down 1% from fourth quarter 2001
• Chemicals: in 2001, the chemicals industry made huge reductions in its spending
• France: although France has the second largest pharmaceutical market in Europe and conducts state-of-the-art biological research, its biotech sector lags behind those of other European countries
• Canada: a report by Ernst & Young, "Beyond Borders: the Canadian Biotechnology Report 2002", discusses the potential problems for a large biotech industry primarily comprised of small companies
• Europe: this month, the European Parliament published the new Framework Program for Research and Technological Development for 2002-2006
• Companies
• Products
• Executive changes
• Market profile: FFF
• The bottom line: data from recent industry financial reports. Dollar amounts in million